portal hypertensive enteropathy
Conditions
Interventions
portal hypertensive enteropathy group and non portal hypertensive enteropathy group:Nil
Sponsors
Shanghai Tongji Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18-75 years; 2) Liver cirrhosis was confirmed by clinical or pathological biopsy; 3) No liver transplantation was received and the expected survival time was more than 24 months; 4) Sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: The contraindications of magnetic capsule endoscopy (MCE) include: 1. Absolute contraindications: (1) Patients who have no operation conditions or refuse any abdominal surgery (once the capsule is retained, it will not be able to be removed by surgery); (2) Cardiac pacemaker is installed in the body, except that the pacemaker is a new MRI compatible product; (3) Cochlear implant, magnetic metal drug infusion pump, nerve stimulator and magnetic metal foreign body were implanted into the body; (4) Pregnant women 2. Relative contraindications: (1) Gastrointestinal obstruction, stenosis and fistula are known or suspected; (2) Dysphagia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| portal hypertensive enteropathy;esophageal and gastric varices;portal hypertensive gastropathy;noninvasive measurement of portal vein pressure;Fecal occult blood test;Child-Pugh grade of liver function;splenomegaly;ascites;Serum endotoxin test;collateral circulation; | — |
Countries
China
Contacts
Public ContactYang Changqing
Gastroenteropathy Department, Shanghai Tongji Hospital
Outcome results
None listed